PMS-DOCETAXEL 80 MG / 2 ML
DOCETAXEL : 80 MG / 2 ML · DIN 02436388 · PHARMASCIENCE INC
Health Canada status: CANCELLED PRE MARKET
What is PMS-DOCETAXEL?
PMS-DOCETAXEL 80 MG / 2 ML contains DOCETAXEL : 80 MG / 2 ML. It is listed in the Health Canada Drug Product Database under DIN 02436388, held by PHARMASCIENCE INC, supplied as KIT ; SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 15-Mar-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02436388 |
|---|---|
| Brand name | PMS-DOCETAXEL |
| Generic / active ingredient | DOCETAXEL : 80 MG / 2 ML |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 80 MG / 2 ML |
| Dosage form | KIT ; SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01CD02 DOCETAXEL |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 15-Mar-2023 |
Is DOCETAXEL in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANDOZ CANADA INCORPORATED, last seen 03 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code L01CD02 DOCETAXEL. 3 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DOCETAXEL INJECTION | 10 MG | Injection | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02439336 |
| DOCETAXEL INJECTION | 20 MG | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED | DIN 02458020 |
| DOCETAXEL INJECTION USP | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02361957 |
| ACT DOCETAXEL 40 MG/ML | 20 MG / 0.5 ML | SOLUTION | ACTAVIS PHARMA COMPANY | CANCELLED PRE MARKET | DIN 02444410 |
| ACT DOCETAXEL 40 MG/ML | 80 MG / 2 ML | SOLUTION | ACTAVIS PHARMA COMPANY | CANCELLED PRE MARKET | DIN 02441845 |
| DOCETAXEL INJECTION | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | DORMANT | DIN 02437031 |
| DOCETAXEL INJECTION | 20 MG / 0.72 ML | SOLUTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02412225 |
| DOCETAXEL INJECTION | 80 MG / 2.88 ML | SOLUTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02412233 |
| PMS-DOCETAXEL | 20 MG / 0.5 ML | KIT ; SOLUTION | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02436361 |
| TARO-DOCETAXEL | 160 MG / 8 ML | SOLUTION | TARO PHARMACEUTICALS INC | CANCELLED PRE MARKET | DIN 02465655 |
Who else supplies DOCETAXEL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOCETAXEL appears in 172 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.